Datadog (NASDAQ: DDOG) and Snowflake (NYSE: SNOW) both help companies optimize their businesses with AI-powered applications. Datadog collects diagnostic data from a wide range of software ...
Palantir Technologies (NYSE: PLTR) and Microsoft (NASDAQ: MSFT) have both profited from the rapid expansion of the artificial intelligence (AI) market. Palantir aggregates large amounts of data ...
Both the electric carmaker Tesla (NASDAQ: TSLA) and the electric aircraft maker Archer Aviation (NYSE: ACHR) are poised to benefit as the world adopts electric vehicles as a sustainable ...
In the meantime, MGM Resorts International Inc. (NYSE: MGM) has grown to operate ... MGM Resorts and Caesars Entertainment Inc. (NASDAQ: CZR). MGM operates a total of 18 U.S. and Macau properties.
Shares of Palantir Technologies (NYSE: PLTR) and Nvidia (NASDAQ: NVDA) have skyrocketed 223% and 194%, respectively, this year, as of Nov. 6 amid strong demand for artificial intelligence (AI).
30.8% of Atomera shares are held by institutional investors. Comparatively, 5.1% of United Microelectronics shares are held by institutional investors. 13.0% of Atomera shares are held by insiders ...
Wall Street funds surged up to 21% after the recent political events, while China-based funds saw smaller gains. Experts ...
The most popular stock in the artificial intelligence (AI) software space is undoubtedly Palantir (NYSE: PLTR ... want to be when they grow up: Adobe (NASDAQ: ADBE). Adobe's stock is down ...
In one corner, Walmart (NYSE: WMT) stock is having a banner year, up 54% amid a string of better-than-expected results. On the other side, Dollar General (NYSE: DG) has struggled to manage weak ...
Over the past 12 months, Palantir's stock has soared more than 170% as Microsoft's stock rose by less than 20%. Let's see why ...
Leading courier and shipping service providers like United Parcel Service Inc. (NYSE: UPS) and FedEx Corp. (NYSE: FDX) stand to benefit from a surge in holiday gift shipments. These companies also ...
Investors continued to see multiple shades of light red as biotechs continued to struggle in the wake of the postelection ...